Halo Diagnostics (or Dx for short) has raised a $19 million Series A to improve diagnosis of several serious illnesses by crossing the streams from multiple tests and making the improved process easily available to providers. An added obstacle is that multi-modal testing isn't really the kind of thing medical imaging or testing providers just decide to get into.